CLEC1A

Chr 12

C-type lectin domain family 1 member A

Also known as: CLEC-1, CLEC1

This gene encodes a C-type lectin that functions in cell adhesion, cell-cell signaling, and immune response regulation, particularly in dendritic cell function. Mutations cause increased susceptibility to aspergillosis, a fungal infection that can affect multiple organ systems including the lungs and central nervous system. The gene shows autosomal inheritance and is not highly constrained against loss-of-function variants.

Summary from RefSeq, OMIM
Research Assistant →

Primary Disease Associations & Inheritance

{Aspergillosis, susceptibility to}MIM #614079
0
Active trials
2
Pubs (1 yr)
37
P/LP submissions
0%
P/LP missense
1.93
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCLEC1A
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
37 unique Pathogenic / Likely Pathogenic· 36 VUS of 83 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.93LOEUF
pLI 0.000
Z-score -1.86
OE 1.55 (1.081.93)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.15Z-score
OE missense 1.03 (0.911.18)
155 obs / 149.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.55 (1.081.93)
00.351.4
Missense OE1.03 (0.911.18)
00.61.4
Synonymous OE0.90
01.21.6
LoF obs/exp: 21 / 13.6Missense obs/exp: 155 / 149.8Syn Z: 0.59
DN
0.7229th %ile
GOF
0.6735th %ile
LOF
0.2483th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

83 submitted variants in ClinVar

Classification Summary

Pathogenic35
Likely Pathogenic2
VUS36
Likely Benign9
Benign1
35
Pathogenic
2
Likely Pathogenic
36
VUS
9
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
35
0
35
Likely Pathogenic
0
0
2
0
2
VUS
0
31
5
0
36
Likely Benign
0
9
0
0
9
Benign
0
1
0
0
1
Total04142083

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CLEC1A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →